CRISPR Therap (CRSP.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec4

Rhumbline Advisers Acquired CRISPR Therapeutics AG Shares in Q2

10:55

Dec1

Crispr Therapeutics May Be Acquired, Potential Buyer Hires Advisors

17:03

Nov27

ETH Zurich Develops StealTHY Platform to Solve CRISPR Immune Interference

04:51

Nov24

ARK Invest Increases Investment in Biotech and Deep Tech Stocks

11:31

Nov17

Scientists Reveal FOXP3 Gene Regulatory Mechanism, Pave Way for New Immunotherapy

04:47

Nov16

Crispr Therapeutics Gene Editing Therapy Significantly Lowers Cholesterol Levels

08:07

Schedules & Filings

Schedules

Filings

Nov10

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 889 K, Net Income -106.44 M, EPS -1.1699

Aug4

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 892 K, Net Income -208.55 M, EPS -2.4

May6

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 865 K, Net Income -136 M, EPS -1.5824

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change